Current CCAAP Research
Diagnosis and Treatment of Sepsis
Volunteers learn how to screen patients for sepsis, one of the leading causes of death in ICUs world-wide. This data is being used to evaluate the current sepsis treatments at OHSU.
Insulin Control in the Critically Ill
Intensive Insulin Therapy is an emerging treatment for hyperglycemia in the critically ill. However, there is still much data that needs to be gathered for this topic of study. Volunteers screen for specific treatment protocols in the ICUs, and then gather data from the patients’ charts and bedsides.
Stop Hypernatremia, Use Metolazone
This investigator-initiated clinical trial is testing whether the addition of a thiazide diuretic will reduce the hypernatremia rates for OHSU's patients receiving diuretics in the ICUs. Volunteers screen patients for study inclusion and assist the study team when active study patients are in the ICU.
Past CCAAP Research
Ventilator-Associated Pneumonia (VAP) Bundle Compliance: provided statistics to managers and staff regarding the compliance with VAP prevention bundle in place at OHSU's Cardiac and Medical Intensive Care Unit.
STIP: Statin Trial for Influenza Patients: multi-center, randomized, double-blinded, placebo-controlled clinical trial of the novel use of statins for the treatment of acute lung injury associated with influenza.
PROWESS-Shock Trial (sponsored by Eli Lilly Co.): multi-center, randomized, double-bind, placebo-controlled clinical trial of the safety and efficacy of activated human protein C in patients with severe sepsis and septic shock. ClinTrials.gov #NCT00604214.